The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man.

Suppr

超能文献

作者信息

Schein P S, Davis R D, Carter S, Newman J, Schein D R, Rall D P

出版信息

Clin Pharmacol Ther. 1970 Jan-Feb;11(1):3-40. doi: 10.1002/cpt19701113.

DOI:10.1002/cpt19701113

PMID:4983384

Abstract

摘要

相似文献

The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man.

Clin Pharmacol Ther. 1970 Jan-Feb;11(1):3-40. doi: 10.1002/cpt19701113.

The efficacy of animal studies in predicting clinical toxicity of cancer chemotherapeutic drugs.动物研究在预测癌症化疗药物临床毒性方面的有效性。

Int J Clin Pharmacol. 1973 Nov;8(3):228-38.

cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.顺式二氯二氨合铂（II）（NSC - 119875）：在犬、猴和小鼠中静脉注射的临床前毒理学评估

Toxicol Appl Pharmacol. 1973 Jun;25(2):230-41. doi: 10.1016/s0041-008x(73)80009-2.

Dose limiting extramedullary toxicity of high dose chemotherapy.高剂量化疗的剂量限制性髓外毒性

Exp Hematol. 1979;7 Suppl 5:265-78.

Adverse reactions to cytostatic agents.细胞毒性药物的不良反应。

Recent Results Cancer Res. 1975(52):36-41. doi: 10.1007/978-3-642-80940-8_4.

Adjuvant chemotherapy using cisplatin by subcutaneous administration.采用皮下给药方式使用顺铂进行辅助化疗。

In Vivo. 1997 Jul-Aug;11(4):345-50.

Effects of organic solvents.有机溶剂的影响。

Br J Hosp Med. 1981 Dec;26(6):645-9.

5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196)--clinical brochure.5（或4）-[3,3-双（2-氯乙基）-1-三氮烯基]咪唑-4（或5）-甲酰胺（NSC-82196）——临床手册

Cancer Chemother Rep 3. 1968 Dec;1(1):63-80.

The pathophysiology and pathoanatomy of reactions to antimicrobial agents.对抗菌药物反应的病理生理学和病理解剖学。

Adv Intern Med. 1974;19:109-34.

The clinical pharmacology of hexamethylmelamine: Phase I study.六甲蜜胺的临床药理学：I期研究。

Clin Pharmacol Ther. 1967 Jan-Feb;8(1):55-64. doi: 10.1002/cpt196781part155.

引用本文的文献

Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties.桑给巴尔霉素在体外对 SARS-CoV-2 具有高度有效性，且具有良好的药物特性。

JCI Insight. 2022 Jan 11;7(1):e153165. doi: 10.1172/jci.insight.153165.

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures.一种新型埃博拉病毒 VP40 基质蛋白为基础的筛选方法，用于鉴定新型候选医疗对策。

Viruses. 2020 Dec 31;13(1):52. doi: 10.3390/v13010052.

Pre-clinical animal models are poor predictors of human toxicities in phase 1 oncology clinical trials.临床前动物模型预测 1 期肿瘤临床试验人体毒性的能力较差。

Br J Cancer. 2020 Nov;123(10):1496-1501. doi: 10.1038/s41416-020-01033-x. Epub 2020 Sep 1.

Animal to human translation: a systematic scoping review of reported concordance rates.动物到人类的转化：报告的一致性率的系统范围综述。

J Transl Med. 2019 Jul 15;17(1):223. doi: 10.1186/s12967-019-1976-2.

The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma.维替泊芬作为黑色素瘤临床前模型治疗选择的有效性

J Cancer. 2019 Jan 1;10(1):1-10. doi: 10.7150/jca.27472. eCollection 2019.

Pharmacological vs. classical approaches in the design of first in man clinical drug trials.首次人体临床试验设计中的药理学方法与传统方法对比

Br J Clin Pharmacol. 2017 Dec;83(12):2807-2812. doi: 10.1111/bcp.13422. Epub 2017 Oct 6.

Developing drug prototypes: pharmacology replaces safety and tolerability?药物原型开发：药理学取代安全性和耐受性？

Nat Rev Drug Discov. 2010 Nov;9(11):856-65. doi: 10.1038/nrd3227. Epub 2010 Sep 17.

Models for prevention and treatment of cancer: problems vs promises.癌症防治模型：问题与前景

Biochem Pharmacol. 2009 Nov 1;78(9):1083-94. doi: 10.1016/j.bcp.2009.05.027. Epub 2009 May 27.

Opportunities for the replacement of animals in the study of nausea and vomiting.在恶心和呕吐研究中替代动物的机会。

Br J Pharmacol. 2009 Jul;157(6):865-80. doi: 10.1111/j.1476-5381.2009.00176.x. Epub 2009 Apr 9.

Medical progress depends on animal models - doesn't it?医学进步依赖于动物模型——难道不是吗？

J R Soc Med. 2008 Feb;101(2):95-8. doi: 10.1258/jrsm.2007.070164.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验